Integrative and Multi-Modality Therapy in the Next Generation of Hepatocellular Carcinoma Management

Dear Colleagues,

In the last few years, there has been a seismic shift in the available therapies for hepatocellular carcinoma (HCC). Multidisciplinary care encompasses surgical, interventional radiology, transplant, radiation and systemic therapy options, including the potential use of systemic therapies for HCC in the neo-adjuvant, adjuvant and advanced settings.

This Special Issue is looking for original manuscripts and reviews to explore all areas of treatment, including the following:

1. Screening approaches;
2. Cirrhosis management in the setting of HCC;
3. Molecular classification, prognostic, and predictive biomarkers;
4. New approaches in both interventional radiology, radiation, and surgical procedures;
5. Approaches of neo-adjuvant strategies and adjuvant therapies;
6. Multi-modality therapy in the advanced and metastatic setting;
7. Therapy sequencing in early and advanced disease;
8. Developments in immunotherapy and immunotherapy-based combinations.

We look forward to receiving your contributions.

Dr. Brandon M. Meyers
Dr. Howard Lim
Dr. Anand Swaminath
Dr. Pablo Emilio Serrano
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• hepatocellular carcinoma
• HCC
• multi-modality therapy
• surgical therapy
• interventional radiology
• transplant
• radiation therapy
• systemic therapy
• immunotherapy and immunotherapy-based combinations